Gilead Sciences (GILD)

$66.69 0.10 (0.15%)

16:00 EDT GILD Stock Quote Delayed 30 Minutes

Why Is Gilead Sciences (GILD) Stock Up Today?

By Bret Kenwell, InvestorPlace Contributor Sep 12, 2022

Gilead Sciences has a low valuation, but no growth. Perhaps settling a patent lawsuit will help give GILD stock the boost it needs.

What Is Going on With Gilead Sciences (GILD) Stock Today?

7 Growth Stocks to Buy After a 20% Correction

7 Best Pharmaceutical Stocks to Buy Now

Volume:

Previous Close -

Market Cap 83.62B

PE Ratio 190.54

EPS 0.35

Volume (Avg. Vol.) 4.21M

Day's Range $66.01 - $66.93

52-Week Range $62.07 - $87.86

Dividend & Yield $3.00 (4.50%)

GILD Stock Predictions, Articles, and Gilead Sciences News

7 Biotech Stocks With Key Catalysts Coming in July

By Tezcan Gecgil, InvestorPlace Contributor Jun 27, 2022

Biotech stocks have suffered significant setbacks during the first half of the year but are likely to bounce back soon

7 Oversold Stocks to Buy Right Now

By Tezcan Gecgil, InvestorPlace Contributor Jun 8, 2022

Identifying oversold stocks gives investors the opportunity to buy shares that they perhaps already liked, only at a discounted price.

7 Safe Dividend Stocks With High Yields to Buy Now

By Chris Markoch, InvestorPlace Contributor May 31, 2022

Investors are seeking dividend stocks. Here are seven safe dividend stocks that offer a high yield to maximize their total return.

7 Dividend Stocks Paying Over 5% to Buy Now

By Chris Lau, InvestorPlace Contributor Apr 26, 2022

Stock markets will return less this year as interest rates rise and cause a recession, so investors should demand higher yield.

The 7 Highest Dividend Stocks for Income Investors

By Louis Navellier and the InvestorPlace Research Staff Feb 9, 2022

These dividend stocks, including SCCO stock and CQP stock, offer high yields, a proven track record and high ratings in Dividend Grader.

5 Biotech Stocks to Buy to Benefit From Biden’s New Cancer Cabinet

By Samuel O'Brient, InvestorPlace Reporter Feb 4, 2022

Joe Biden is redoubling his efforts to fight cancer with a new "cancer cabinet." Here are the biotech stocks to buy that can benefit.

7 Safe Stocks for Your Retirement

By Louis Navellier and the InvestorPlace Research Staff Jan 7, 2022

In a dynamic market like the one we're in now, it's important to buy safe stocks that will build your nest egg in the years to come.

7 Pharmaceutical Stocks That Could Make You Rich

By Tezcan Gecgil, InvestorPlace Contributor Jan 6, 2022

These seven pharmaceutical stocks could create lucrative opportunities in the new year

5 M&A Stocks to Watch as Goldman Calls for a Big Jump in Deals

By Samuel O'Brient, InvestorPlace Reporter Nov 1, 2021

Goldman Sachs predicts the Democrats' new tax plan could yield positive results for M&A-focused companies. Here are the M&A stocks to watch.

3 Value Stocks to Buy While You Still Can

By David Cohne, StockNews.com Sep 20, 2021

Value stocks have been underperforming over the past few months, but that is expected to change as the economy continues to recover.

7 Stocks to Buy for Responsibility and Sustainability

By Josh Enomoto, InvestorPlace Contributor Aug 4, 2021

With social responsibility taking a greater role in politics and Wall Street, these ESG stocks may find favor in your portfolio.

10 Best Stocks to Buy to Build Up Passive Income Streams

By Ian Bezek, InvestorPlace Contributor Jun 24, 2021

These income stocks boast huge dividend growth rates and should generate large passive income streams over the next decade.

7 Former Pandemic Stocks to Buy That Are No Longer Running Hot

By Josh Enomoto, InvestorPlace Contributor May 26, 2021

The pandemic bolstered many stocks to buy. But with cases fading, this narrative is now questionable. These seven stocks require caution.

2 Must-Own Biotech Stocks to Buy in May

By David Cohne, StockNews.com Apr 29, 2021

After a stellar rally in 2020, biotech stocks have been selling off over the past couple of months. This offers investors a buying opportunity to scoop up quality biotech stocks at cheaper prices.

Vaccitech IPO: When Does Vaccitech Go Public? What Is the VACC Stock IPO Price Range?

By Chris MacDonald, InvestorPlace Contributor Apr 28, 2021

The upcoming Vaccitech IPO is one I think investors will have their eye on, as speculators look for early stage biopharma plays today.

7 Pharmaceutical Stocks With Dividends in Hand

By Thomas Niel, InvestorPlace Contributor Apr 28, 2021

So, which pharmaceutical stocks should be on your radar, if dividends are a top priority? Consider these seven compelling opportunities.

7 Healthcare Stocks for a Reopening World

By Tezcan Gecgil, InvestorPlace Contributor Apr 26, 2021

The stock market is at all-time highs, and the world is starting to reopen. But these healthcare stocks have more growth opportunities ahead.

7 Healthcare Stocks to Buy to Prepare Your Portfolio For The Next Pandemic

By Tezcan Gecgil, InvestorPlace Contributor Apr 1, 2021

Covid-19 has put healthcare stocks in the limelight. These seven companies should be on your radar for the next pandemic.

7 Value Stocks Everyone Is Ignoring

By Tezcan Gecgil, InvestorPlace Contributor Mar 24, 2021

Blue chips and companies on the rebound. Here are seven of the best value stocks for long-term investors.

7 High-Yield Stocks for Your Retirement Nest Egg

By Tom Taulli, InvestorPlace Contributor Mar 15, 2021

High-dividend names are some of the best retirement stocks and can be a good way to achieve strong long-term growth for your portfolio.

Gilead Sciences (GILD)

Why Is Gilead Sciences (GILD) Stock Up Today?

What Is Going on With Gilead Sciences (GILD) Stock Today?

7 Growth Stocks to Buy After a 20% Correction

7 Best Pharmaceutical Stocks to Buy Now

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Gilead Sciences (GILD)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

GILD Stock Predictions, Articles, and Gilead Sciences News

Subscriber Sign in